FR3090384B1 - Pro-vitamin effect of an extract of a probiotic microorganism - Google Patents

Pro-vitamin effect of an extract of a probiotic microorganism Download PDF

Info

Publication number
FR3090384B1
FR3090384B1 FR1873827A FR1873827A FR3090384B1 FR 3090384 B1 FR3090384 B1 FR 3090384B1 FR 1873827 A FR1873827 A FR 1873827A FR 1873827 A FR1873827 A FR 1873827A FR 3090384 B1 FR3090384 B1 FR 3090384B1
Authority
FR
France
Prior art keywords
extract
pro
probiotic microorganism
vitamin effect
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1873827A
Other languages
French (fr)
Other versions
FR3090384A1 (en
Inventor
Marc Dumas
Catherine Heusele
Valérie Gorzelanczyk
Olivier Jeanneton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Priority to FR1873827A priority Critical patent/FR3090384B1/en
Priority to PCT/EP2019/086085 priority patent/WO2020127577A1/en
Publication of FR3090384A1 publication Critical patent/FR3090384A1/en
Application granted granted Critical
Publication of FR3090384B1 publication Critical patent/FR3090384B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria

Abstract

La présente invention concerne l’utilisation d’au moins un extrait d’un microorganisme probiotique, l’une de ses fractions et/ou un de ses métabolites, dans une composition pour application topique sur les matières kératiniques, comme agent provitaminique.The present invention relates to the use of at least one extract of a probiotic microorganism, one of its fractions and / or one of its metabolites, in a composition for topical application to keratin materials, as a provitaminic agent.

FR1873827A 2018-12-21 2018-12-21 Pro-vitamin effect of an extract of a probiotic microorganism Active FR3090384B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1873827A FR3090384B1 (en) 2018-12-21 2018-12-21 Pro-vitamin effect of an extract of a probiotic microorganism
PCT/EP2019/086085 WO2020127577A1 (en) 2018-12-21 2019-12-18 Pro-vitamin effect of an extract of a probiotic microorganism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1873827A FR3090384B1 (en) 2018-12-21 2018-12-21 Pro-vitamin effect of an extract of a probiotic microorganism

Publications (2)

Publication Number Publication Date
FR3090384A1 FR3090384A1 (en) 2020-06-26
FR3090384B1 true FR3090384B1 (en) 2021-05-28

Family

ID=66641092

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1873827A Active FR3090384B1 (en) 2018-12-21 2018-12-21 Pro-vitamin effect of an extract of a probiotic microorganism

Country Status (2)

Country Link
FR (1) FR3090384B1 (en)
WO (1) WO2020127577A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023159478A1 (en) * 2022-02-25 2023-08-31 L'oreal Composition for caring for keratin materials and mask containing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160024149A1 (en) * 2008-04-17 2016-01-28 Trustees Of Dartmouth College Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same
FR2938429B1 (en) 2008-11-19 2012-05-18 Oreal COSMETIC USE OF MICROORGANISM (S) FOR THE TREATMENT OF SKIN LEATHER DISORDERS
IT1398730B1 (en) * 2009-09-08 2013-03-18 Giuliani Spa PROBIOTIC BACTERIAL STRAIN AND ITS USES BY ORAL AND TOPIC ROUTE
FR2953408B1 (en) * 2009-12-08 2013-02-08 Oreal ACTIVE PROBIOTIC MICROORGANISMS FOR SKIN DYE SKIN
GB2556841B (en) * 2015-09-18 2019-04-10 Virun Inc Emulsion compositions comprising mucoadhesive proteins and agents that degrade in water
KR101938865B1 (en) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 Composition for preventing or treating bone disease, obesity and lipid-related metabolic disease
KR101938864B1 (en) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 Composition for antioxidation and improvement of skin conditions
KR20180049731A (en) * 2016-11-03 2018-05-11 주식회사 쎌바이오텍 Composition for preventing or treating obesity and lipid-related metabolic disease

Also Published As

Publication number Publication date
WO2020127577A1 (en) 2020-06-25
FR3090384A1 (en) 2020-06-26

Similar Documents

Publication Publication Date Title
WO2020039321A8 (en) Anti-gdf15 antibodies, compositions and methods of use
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
PH12020500240A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
CL2018003758A1 (en) Anti-dll3-antibody antibody conjugates and methods of use. (divisional application 201800458)
MX2020009313A (en) Compositions and methods for skin renewal.
MX2018013038A (en) Anti-il-33 antibodies, compositions, methods and uses thereof.
UA112416C2 (en) FAP ANTIBODY AND METHODS OF ITS APPLICATION
EA201900561A1 (en) CONJUGATES OF CYCLODEXTRIN-PROTEIN-MEDICINE
EA202190609A1 (en) ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF APPLICATION ANTIBODIES AGAINST HLA-G
WO2020051333A8 (en) Anti-avb8 antibodies and compositions and uses thereof
BR112021012667A2 (en) Anti-pd-1 binding proteins and methods of using them
EA201992520A1 (en) OIL IMPROVING COMPOSITION FOR SKIN
EP3964199A4 (en) Stable gel composition having high oil content, and preparation method therefor and application thereof
MX2021007274A (en) Bifunctional anti-pd-1/sirpa molecule.
MX2020002435A (en) Agents modulating beta-catenin functions and methods thereof.
MX2017009680A (en) Single domain antibodies targeting cd1d.
MX2021000719A (en) Fecal microbiota composition, for use in reducing treatment-induced inflammation.
EP1576950A3 (en) Tapioca in cosmetic compositions
FR3090384B1 (en) Pro-vitamin effect of an extract of a probiotic microorganism
EA201890119A1 (en) MIXED COMPOSITIONS
EP3998110A4 (en) Liquid cosmetic composition
SA519401424B1 (en) CMET Monoclonal Binding Agents Drug Conjugates Thereof and Uses Thereof
EA202190201A1 (en) COMPOSITIONS FOR TUMOR SIZE REDUCTION AND METHODS FOR THEIR APPLICATION
BR112019006009A2 (en) non-therapeutic method, particle or composition and use
MX2021015473A (en) Novel antibodies specific for cthrc1 and use thereof.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200626

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6